<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; ball</title>
	<atom:link href="http://www.tapanray.in/tag/ball/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>&#8216;Made-to-Measure&#8217; Marketing for &#8216;Made-to-Measure&#8217; Medicines</title>
		<link>http://www.tapanray.in/made-to-measure-marketing-for-made-to-measure-medicines/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=made-to-measure-marketing-for-made-to-measure-medicines</link>
		<comments>http://www.tapanray.in/made-to-measure-marketing-for-made-to-measure-medicines/#comments</comments>
		<pubDate>Mon, 26 Mar 2018 00:00:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA['Made-to-Measure']]></category>
		<category><![CDATA[ball]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[diseases]]></category>
		<category><![CDATA[dosage]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Herceptin]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[marketers]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[personalized]]></category>
		<category><![CDATA[Precision]]></category>
		<category><![CDATA[rare]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[USFDA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8867</guid>
		<description><![CDATA[We have entered into a new era of innovation in medical science where ‘one size fits all’ type of treatment is making a sizeable space for a new ‘made-to-measure’ variety of the same. Such medicines are being developed particularly for &#8230; <a href="http://www.tapanray.in/made-to-measure-marketing-for-made-to-measure-medicines/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/made-to-measure-marketing-for-made-to-measure-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘The Pharmacy of the Developing World’ keeps its eye on the ball to emerge as ‘The Pharmacy of the World’</title>
		<link>http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world</link>
		<comments>http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/#comments</comments>
		<pubDate>Sun, 28 Oct 2012 00:00:25 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abbott]]></category>
		<category><![CDATA[as]]></category>
		<category><![CDATA[ball]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[Compulsory Licensing]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[Developing]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[emerge]]></category>
		<category><![CDATA[Ethical Marketing]]></category>
		<category><![CDATA[eye]]></category>
		<category><![CDATA[FDI]]></category>
		<category><![CDATA[glaxo]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[keeps]]></category>
		<category><![CDATA[kopran]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[Medical Diagnostics]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Neutraceutical]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[OPPI]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[PHC]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research & Development]]></category>
		<category><![CDATA[sami]]></category>
		<category><![CDATA[Spurious]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[therapeutic]]></category>
		<category><![CDATA[Trials]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1075</guid>
		<description><![CDATA[The incessant march of the home grown pharmaceutical companies of India in search of excellence, especially in the space of high quality low cost generic medicines for almost all disease areas, continues at a scorching space, probably more than ever &#8230; <a href="http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Balancing Strong IP Protection, Public Health Safeguards and Declining R&amp;D Productivity &#8211; A Crafty Gutsy Ball Game</title>
		<link>http://www.tapanray.in/balancing-strong-ip-protection-public-health-safeguards-and-declining-rd-productivity-a-crafty-gutsy-ball-game/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=balancing-strong-ip-protection-public-health-safeguards-and-declining-rd-productivity-a-crafty-gutsy-ball-game</link>
		<comments>http://www.tapanray.in/balancing-strong-ip-protection-public-health-safeguards-and-declining-rd-productivity-a-crafty-gutsy-ball-game/#comments</comments>
		<pubDate>Mon, 16 Apr 2012 00:00:39 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Balancing]]></category>
		<category><![CDATA[ball]]></category>
		<category><![CDATA[Crafty]]></category>
		<category><![CDATA[Declining]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Gutsy]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[productivity]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Safeguards]]></category>
		<category><![CDATA[Strong]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[WTO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=107</guid>
		<description><![CDATA[Pharmaceutical innovation has always been considered the lifeblood for the pharmaceutical industry and very rightly so. However, many studies do point out that such innovation has benefited the developed world more than the developing world. Product Price and Access: In &#8230; <a href="http://www.tapanray.in/balancing-strong-ip-protection-public-health-safeguards-and-declining-rd-productivity-a-crafty-gutsy-ball-game/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/balancing-strong-ip-protection-public-health-safeguards-and-declining-rd-productivity-a-crafty-gutsy-ball-game/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantum Growth Envisaged in Government Procurement for Pharmaceuticals: A Challenging Ball Game for Pharma Players</title>
		<link>http://www.tapanray.in/quantum-growth-envisaged-in-government-procurement-for-pharmaceuticals-a-challenging-ball-game-for-pharma-players/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=quantum-growth-envisaged-in-government-procurement-for-pharmaceuticals-a-challenging-ball-game-for-pharma-players</link>
		<comments>http://www.tapanray.in/quantum-growth-envisaged-in-government-procurement-for-pharmaceuticals-a-challenging-ball-game-for-pharma-players/#comments</comments>
		<pubDate>Mon, 27 Feb 2012 00:00:25 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[ball]]></category>
		<category><![CDATA[Challenging]]></category>
		<category><![CDATA[Envisaged]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Players]]></category>
		<category><![CDATA[Procurement]]></category>
		<category><![CDATA[Quantum]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=128</guid>
		<description><![CDATA[Direct procurement by the Governments of various countries is attracting increasing importance not just at the domestic level, but internationally, as well. The systems adopted for Government Procurement (GP) globally are aimed at making a significant difference in the effectiveness &#8230; <a href="http://www.tapanray.in/quantum-growth-envisaged-in-government-procurement-for-pharmaceuticals-a-challenging-ball-game-for-pharma-players/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/quantum-growth-envisaged-in-government-procurement-for-pharmaceuticals-a-challenging-ball-game-for-pharma-players/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
